Skip to main content

Metabolism and Tissue Residues

  • Chapter
Ivermectin and Abamectin

Abstract

Ivermectin is used widely as an antiparasitic agent in food-producing animals. As in the case of any such drug, the residual tissue concentration of the therapeutic agent, or tissue residue, is a safety concern to the meat-consuming public. To evaluate the toxic potential of the residual tissue concentration of ivermectin and its metabolites, metabolism studies have been carried out in target species (cattle, sheep, swine) using the radiolabeled drug. Comparative metabolic studies were done in a laboratory animal, the rat, and in liver microsomes from various species.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Caldwell J, Marsh MV (1983) Interrelationships between xenobiotic metabolism and lipid biosynthesis. Biochem. Pharm. 32:1667–1672

    Article  PubMed  CAS  Google Scholar 

  • Campbell WC, Fisher MH, Stapley EO, Albers-Schonber G, Jacob TA (1983) Ivermectin: A potent new antiparasitic agent. Science 221:923–928

    Google Scholar 

  • Chiu SHL, Buhs RP, Sestokas E, Taub R, Jacob TA (1985) Determination of ivermectin residue in animal tissues by high performance liquid chroma- tography-reverse isotope dilution assay. J. Agric. Food Chem. 33:99–102

    Article  CAS  Google Scholar 

  • Chiu SHL, Carlin JR, Taub R, Sestokas E, Zweig J, VandenHeuval WJA, Jacob TA (1988) Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats. Drug Me tab. & Dispos. 16:728–736

    CAS  Google Scholar 

  • Chiu SHL, Sestokas E, Taub R, Buhs RP, Green M, Sestokas R, VandenHeuvel WJA, Arison BH, Jacob TA (1986) Metabolic disposition of ivermectin in tissues of steers, sheep, and rats. Drug Metab. & Dispos. 14:590–600

    CAS  Google Scholar 

  • Chiu SHL, Sestokas E, Taub R, Smith JL, Arison B, Lu AYH (1984) The metabolism of avermectin-H2B1a and -H2B1b by pig liver microsomes. Drug Metab. & Dispos. 12:464–469

    CAS  Google Scholar 

  • Chiu SHL, Taub R, Sestokas E, Lu AYH, Jacob TA (1987) Comparative in vivo and in vitro metabolism of ivermectin in steers, sheep, swine, and rat. Drug Metab. Rev. 18:289–302

    Article  PubMed  CAS  Google Scholar 

  • Dell HD, Fiedler J, Kamp R, Gaug W, Kurz J, Weber B, Wuensche C (1982) Etofenamate fatty acid esters, an example of a new route of drug metabolism. Drug Metab. & Dispos. 10:55–60

    CAS  Google Scholar 

  • Dorough HW (1980) Classification of radioactive pesticide residues in food- producing animals. J. Environ. Path. Toxicol. 3:11–19

    CAS  Google Scholar 

  • Jacob TA, Buhs RP, Carlin JR, Chiu SHL, Miwa GT, Rosegay A (1983) The metabolism and tissue residue profiles of ivermectin. In Proceedings of the MSD AGVET Symposium on Recent Developments in the Control of Animal Parasites, XXII World Veterinary Congress, Perth, Australia

    Google Scholar 

  • Leighty EG, Fentiman Jr AF, Foltz RL (1976) Long-chain metabolites of Δ9- and Δ8-tetrahydrocannabinols identified as novel fatty acid conjugates. Res. Comm. Chem. Pathol. Pharm. 14:13–28

    CAS  Google Scholar 

  • Lu AYH, Wislocki PG, Chiu SHL, Miwa GT (1987) Tissue drug residues and their toxicological significance. Drug Metab. Reviews 18:363–378

    Article  CAS  Google Scholar 

  • Miwa GT, Walsh JS, VandenHeuvel WJA, Arison B, Sestokas E, Buhs R, Rosegay A, Avermitilis S, Lu AYH, Walsh MAR, Walker RW, Taub R, Jacob TA (1982) The metabolism of avermectins B1a, H2B1a and H2B1b by liver microsomes. Drug Metab. & Dispos. 10:268–274

    CAS  Google Scholar 

  • Pivnichny JV, Shim J-SK, Zimmerman LA (1983) Direct determination of avermectins in plasma at nanogram levels by high-performance liquid chromatography. J. Pharm. Sci. 72:1447–1450

    Article  PubMed  CAS  Google Scholar 

  • Schmid J, Prox A, Baeur E, Koss FW (1980) Abstract No. 434, 7th European Workshop on Drug Metabolism, Zurich

    Google Scholar 

  • Stong JD (1987) Determination of ivermectin by fluorescence derivatization. Anal. Chem. 59:266–270

    Article  PubMed  CAS  Google Scholar 

  • Tolan JW, Eskola P, Fink DW, Mrozik H, Zimmerman LA (1980) Determination of avermectin in plasma at nanogram levels using high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 190:367–376

    Article  PubMed  CAS  Google Scholar 

  • Tway PC, Wood Jr JS, Downing GV (1981) Determination of ivermectin in steers and sheep tissues using high-performance liquid chromatography with fluorescence detection. J. Agric. Food Chem. 29:1059–1063

    Article  PubMed  CAS  Google Scholar 

  • Weber NE (1980) Persistent residues: Interface with regulatory decisions. J. Environ. Path. Toxicol. 3:35–43

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Chiu, SH.L., Lu, A.Y.H. (1989). Metabolism and Tissue Residues. In: Campbell, W.C. (eds) Ivermectin and Abamectin. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3626-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3626-9_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-8184-9

  • Online ISBN: 978-1-4612-3626-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics